85. 特発性間質性肺炎 Idiopathic interstitial pneumonia Clinical trials / Disease details

臨床試験数 : 627 / 薬物数 : 443 - (DrugBank : 120) / 標的遺伝子数 : 99 - 標的パスウェイ数 : 212

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04030026 (ClinicalTrials.gov)	August 8, 2019	11/7/2019	A Study of Nalbuphine(Extended Release) ER in Idiopathic Pulmonary Fibrosis (IPF) for Treatment of C ...	Phase 2, Double-blind, Randomized, Placebo-controlled, Two-Treatment, Two-Period Crossover Efficacy ...	Nalbuphine;Idiopathic Pulmonary Fibrosis;Cough	Drug: Nalbuphine ER;Drug: Placebo oral tablet	Trevi Therapeutics	Parexel	Completed	18 Years	80 Years	All	42	Phase 2	United Kingdom
2	EUCTR2018-004744-31-GB (EUCTR)	24/06/2019	05/03/2019	Efficacy and Safety Study: NalbuphineER Tablets for the Treatment of Cough in Idiopathic Pulmonary F ...	A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Two-Treatment, Two-Period Crossover Efficac ...	Treatment of Cough in Idiopathic Pulmonary Fibrosis;Therapeutic area: Body processes [G] - Circulato ...	Product Name: Nalbuphine Extended-Realease (ER) Tablets Product Code: TR0311 INN or Proposed INN: Nalbu ...	Trevi Therapeutics, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	60	Phase 2	United Kingdom

First Previous1Next Last